BNET Industries
Last Fiscal Year Sales:$37.5M
- Private
- US
Dow Jones Description
Established in the mid-1970s as a cooperative laboratory of experienced scientists, New England Biolabs is a world leader in the production and supply of reagents for the life science industry. NEB now offers the largest selection of recombinant and native enzymes for genomic research and continues to expand its product offerings into areas related to proteomics and drug discovery. After more than 30 years, NEB can be considered one of the first companies to help shape today's biotechnology industry. Housed in a new state-of-the-art facility, NEB's USA headquarters includes a modern fermentation center and fully equipped laboratories for production, quality control, product development and basic research. As one of the first companies to produce restriction enzymes on a commercial scale, NEB continues to specialize in restriction enzymes and consistently maintains a position at the forefront of this field. At New England Biolabs, science has always been a priority and through this approach, NEB's reagents have gained a world-wide reputation for setting the highest of standards for quality and value.
CEO
James EllardNumber of Employees 174
Peer Companies
NAICS Code Surgical and Medical Instrument Manufacturing: 339112
Recent Events
-
Xsigo Systems, Inc.: New England Biolabs Improves Quality of Life With Xsigo
-
New Reagents from New England Biolabs, Inc. Bring Purity and Increased Value to Sample Prep...
News & Analysis
Filter by
new england biolabs inc. - All News and Analysis
New England Biolabs Licenses ERGO™ Genomics Platform to Identify Novel Enzymes and Biological Products in Microbes
- 2007-05-14
CHICAGO & IPSWICH, Mass. -- New England Biolabs NEB, a world leader in the production and supply of reagents for the life science industry, has licensed the ERGO[TM] bioinformatics software developed and maintained by Integrated Genomics. NEB will utilize the ERGO[TM] genome analysis tools for gene annotation, metabolic reconstruction and...
New England Biolabs will provide Solexa with certain key enzymes and other reagents for use with the Solexa Genome Analysis System
- 2006-10-15
New England Biolabs will provide Solexa with certain key enzymes and other reagents for use with the Solexa Genome Analysis System and will manufacture Solexa's sequencing-by-synthesis polymerase.
Solexa and New England Biolabs Announce Enzyme Supply Agreement; New England Biolabs to Manufacture Key Polymerase for the Solexa Genome Analysis System
- 2006-08-01
HAYWARD, Calif. & CAMBRIDGE, England & IPSWICH, Mass. -- Solexa, Inc. (Nasdaq:SLXA) today announced that it has reached an agreement with New England Biolabs Inc. NEB, a leading supplier of enzymes and technologies to the life science market, for NEB to provide Solexa with certain key enzymes and other reagents...
IIR Industry Alert: New England Biolabs Building New Plant on Grounds of Historic Estate
- 2003-04-10
Business Editors/Science Writers HOUSTON--BUSINESS WIRE--April 10, 2003 Researched by Industrialinfo.com (Industrial Information Resources Incorporated; Houston). New England Biolabs (N.E.B.) (Beverly, Mass.) has chosen the 126-acre Proctor Estate in Ipswich, Mass., as the site for construction of their new plant. For details on this project view the entire...
SIGA Announces Research Collaboration with New England Biolabs on Schistosomiasis Vaccine
- 2000-03-30
Business Editors NEW YORK--BUSINESS WIRE--March 30, 2000 SIGA Technologies, Inc. (NASDAQ: SIGA) announced today a research collaboration with New England Biolabs NEB focused on the development of technology for a schistosomiasis vaccine. The collaboration will combine SIGA's proprietary vaccine delivery technology with schistosomiasis antigens identified by NEB...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| James Ellard | CEO |
| Fiona Stewart | Business Development Manager |
| Brian Tinger | Corporate Controller |
| Organization | Position | Status |
|---|---|---|
| New England Biolabs, Inc. | CEO | Current |
| Save One Life, Inc | Board Member | Current |
| Organization | Position | Status |
|---|---|---|
| New England Biolabs, Inc. | Business Development Manager | Current |
Brian is currently the Corporate Controller at New England Biolabs, Inc. located in Ipswich, MA. New England Biolabs is a world leader in the production and supply of reagents for the life science industry with a particular emphasis on recombinant and native enzymes for genomic research. Prior to joining NEB, Brian was an audit manager in the New England office of BDO Seidman, LLP and was with BDO for over 6 years. Brian has been working with the NFS as its treasurer since its inception and he is a member of the American Institute of Certified Public Accountants and the Massachusetts Society of CPAs.
| Organization | Position | Status |
|---|---|---|
| New England Biolabs, Inc. | Corporate Controller | Current |
| Massachusetts Society of CPAs | Board of Directors | Current |
| Newbury Film Series, Inc. | Treasurer | Current |
Industry Transcripts by Seeking Alpha
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT
-
Cytori Therapeutics Q3 2009 Earnings Call Transcript
on Nov 09, 2009about CYTX
-
StoneMor Partners L.P. 3Q09 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 09, 2009about STON
Glass Door
Health Care Industry Companies
| Company | Employer Rating |
| Kaiser Permanente |  |
| Boston Scientific |  |
| WellPoint | |
| UnitedHealth Group |  |
| CIGNA | |
IndustryTop Rated
- Why So Many Insured People Have Big Medical Debts 5 votes
- Physicians Know We Need Reform 4 votes
- Healthcare Roundup: Medical Office Space in Demand, Blues Companies See Lower Income, Two Sides of Health Insurance, and More 3 votes
- Hospital Chain's Turnaround Raises Health Spending 3 votes
- Healthcare Is Still Adding Jobs, Despite Recession 3 votes
